Clodagh Keohane

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

The psychological needs of adolescents and young adults with a diagnosis of myeloproliferative neoplasms: a systematic scoping review of the literature.

The psychological needs of adolescents and young adults with a diagnosis of myeloproliferative neoplasms: a systematic scoping review of the literature.

Journal: Leukemia & lymphoma

Published: February 07, 2024

Incidence and impact of non-canonical JAK2 p.(Val617Phe) mutations in myeloproliferative neoplasm molecular diagnostics.

Incidence and impact of non-canonical JAK2 p.(Val617Phe) mutations in myeloproliferative neoplasm molecular diagnostics.

Journal: Journal of clinical pathology

Published: November 07, 2023

High grade non-germinal centre-like diffuse large B-cell lymphoma double expressor presenting as a hydrocoele.

High grade non-germinal centre-like diffuse large B-cell lymphoma double expressor presenting as a hydrocoele.

Journal: BMJ case reports

Published: January 01, 2022

Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis.

Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis.

Journal: British journal of haematology

Published: February 15, 2021

Essential thrombocythaemia treated with recombinant interferon: 'real world' United Kingdom referral centre experience.

Essential thrombocythaemia treated with recombinant interferon: 'real world' United Kingdom referral centre experience.

Journal: British journal of haematology

Published: February 19, 2019

A multicenter report on the natural history of myelodysplastic syndromes in very old patients (aged over 85 years).

A multicenter report on the natural history of myelodysplastic syndromes in very old patients (aged over 85 years).

Journal: Leukemia & lymphoma

Published: January 12, 2019

The effects of JAK inhibitor therapy upon novel markers of thrombosis In myeloproliferative neoplasms.

The effects of JAK inhibitor therapy upon novel markers of thrombosis In myeloproliferative neoplasms.

Journal: Haematologica

Published: June 20, 2015

JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells.

JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells.

Journal: British journal of haematology

Published: January 16, 2015

Combination therapy with ruxolitinib plus 5-azacytidine or continuous infusion of low dose cytarabine is feasible in patients with blast-phase myeloproliferative neoplasms.

Combination therapy with ruxolitinib plus 5-azacytidine or continuous infusion of low dose cytarabine is feasible in patients with blast-phase myeloproliferative neoplasms.

Journal: British journal of haematology

Published: July 23, 2014

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.

Journal: The New England journal of medicine

Published: December 12, 2013

The diagnosis and management of erythrocytosis.

The diagnosis and management of erythrocytosis.

Journal: BMJ (Clinical research ed.)

Published: November 20, 2013

Practical management of patients with myelofibrosis receiving ruxolitinib.

Practical management of patients with myelofibrosis receiving ruxolitinib.

Journal: Expert review of hematology

Published: October 03, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026